Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 25% ± 6% | |
peripheral blood | 15 studies | 30% ± 10% | |
brain | 13 studies | 33% ± 17% | |
intestine | 7 studies | 26% ± 10% | |
eye | 7 studies | 26% ± 9% | |
liver | 6 studies | 31% ± 18% | |
kidney | 5 studies | 23% ± 6% | |
lymph node | 5 studies | 30% ± 8% | |
bone marrow | 4 studies | 33% ± 11% | |
breast | 4 studies | 22% ± 5% | |
adipose | 4 studies | 26% ± 10% | |
pancreas | 3 studies | 44% ± 23% | |
placenta | 3 studies | 28% ± 4% | |
uterus | 3 studies | 32% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 9086.18 | 459 / 459 | 100% | 94.09 | 1118 / 1118 |
esophagus | 100% | 10049.41 | 1445 / 1445 | 100% | 90.91 | 183 / 183 |
intestine | 100% | 9853.99 | 966 / 966 | 100% | 75.55 | 527 / 527 |
lung | 100% | 9849.05 | 578 / 578 | 100% | 82.39 | 1155 / 1155 |
ovary | 100% | 10592.80 | 180 / 180 | 100% | 57.99 | 430 / 430 |
uterus | 100% | 9435.51 | 170 / 170 | 100% | 86.20 | 459 / 459 |
bladder | 100% | 10162.00 | 21 / 21 | 100% | 75.58 | 503 / 504 |
prostate | 100% | 8178.83 | 245 / 245 | 100% | 73.88 | 501 / 502 |
brain | 100% | 7112.89 | 2633 / 2642 | 100% | 86.10 | 705 / 705 |
stomach | 100% | 7860.38 | 359 / 359 | 100% | 77.77 | 285 / 286 |
thymus | 100% | 7976.19 | 653 / 653 | 100% | 61.82 | 602 / 605 |
skin | 100% | 13911.63 | 1809 / 1809 | 99% | 104.45 | 469 / 472 |
kidney | 100% | 6501.20 | 89 / 89 | 98% | 54.42 | 885 / 901 |
pancreas | 98% | 5058.91 | 323 / 328 | 99% | 57.62 | 176 / 178 |
adrenal gland | 100% | 10159.05 | 258 / 258 | 96% | 56.01 | 221 / 230 |
liver | 100% | 4567.54 | 226 / 226 | 95% | 38.34 | 384 / 406 |
adipose | 100% | 10004.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9041.55 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 91.02 | 29 / 29 |
muscle | 100% | 11504.13 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 10464.76 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 81.73 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 27.44 | 1 / 1 |
peripheral blood | 98% | 13922.12 | 910 / 929 | 0% | 0 | 0 / 0 |
heart | 96% | 6832.59 | 830 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 71.89 | 77 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0040001 | Biological process | establishment of mitotic spindle localization |
GO_0090307 | Biological process | mitotic spindle assembly |
GO_0006606 | Biological process | protein import into nucleus |
GO_0007079 | Biological process | mitotic chromosome movement towards spindle pole |
GO_0030953 | Biological process | astral microtubule organization |
GO_0006610 | Biological process | ribosomal protein import into nucleus |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_0006404 | Biological process | RNA import into nucleus |
GO_0006607 | Biological process | NLS-bearing protein import into nucleus |
GO_0005643 | Cellular component | nuclear pore |
GO_0005576 | Cellular component | extracellular region |
GO_0035580 | Cellular component | specific granule lumen |
GO_0016020 | Cellular component | membrane |
GO_0071782 | Cellular component | endoplasmic reticulum tubular network |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005635 | Cellular component | nuclear envelope |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0042564 | Cellular component | NLS-dependent protein nuclear import complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0031965 | Cellular component | nuclear membrane |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0019904 | Molecular function | protein domain specific binding |
GO_0061676 | Molecular function | importin-alpha family protein binding |
GO_0051879 | Molecular function | Hsp90 protein binding |
GO_0008139 | Molecular function | nuclear localization sequence binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0061608 | Molecular function | nuclear import signal receptor activity |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | KPNB1 |
Protein name | Importin subunit beta-1 Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97) Karyopherin subunit beta 1 |
Synonyms | NTF97 |
Description | FUNCTION: Functions in nuclear protein import, either in association with an adapter protein, like an importin-alpha subunit, which binds to nuclear localization signals (NLS) in cargo substrates, or by acting as autonomous nuclear transport receptor. Acting autonomously, serves itself as NLS receptor. Docking of the importin/substrate complex to the nuclear pore complex (NPC) is mediated by KPNB1 through binding to nucleoporin FxFG repeats and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin-beta and the three components separate and importin-alpha and -beta are re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran from importin. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Mediates autonomously the nuclear import of ribosomal proteins RPL23A, RPS7 and RPL5 . In association with IPO7, mediates the nuclear import of H1 histone. In vitro, mediates nuclear import of H2A, H2B, H3 and H4 histones. In case of HIV-1 infection, binds and mediates the nuclear import of HIV-1 Rev. Imports SNAI1 and PRKCI into the nucleus. . |
Accessions | ENST00000540627.5 [Q14974-2] ENST00000582126.1 J3QR48 ENST00000583648.6 [Q14974-1] J3KS06 J3QKQ5 ENST00000582097.5 J3KTM9 J3QRG4 ENST00000577875.5 ENST00000290158.9 [Q14974-1] ENST00000535458.6 [Q14974-2] ENST00000583648 Q14974 ENST00000583013.1 |